Ben Gerber to Cost-Benefit Analysis
This is a "connection" page, showing publications Ben Gerber has written about Cost-Benefit Analysis.
Connection Strength
0.092
-
Gerber BS, Rapacki L, Castillo A, Tilton J, Touchette DR, Mihailescu D, Berbaum ML, Sharp LK. Design of a trial to evaluate the impact of clinical pharmacists and community health promoters working with African-Americans and Latinos with diabetes. BMC Public Health. 2012 Oct 23; 12:891.
Score: 0.092